Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study
Clinical trial NCT02389972 · COMPLETED
Trial details
- NCT number
- NCT02389972
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-11
- Primary completion
- 2017-07-13
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.